Implantable medical product, comprising a basic body and an imidazole derivative in the form of its free base; wherein said basic body has on its polymeric surface a layer containing the imidazole derivative as an active ingredient, which displays an antithrombogenic, antiproliferative, anti-inflammatory or antiadhesive effect, or a combination thereof.

Disclosed herein are elastic, bioresorbable encasements for medical implants, methods for making the same and uses thereof.

A tube-containing medical device assembly or tube-containing medical device kit can include a tube-containing medical device including an access opening positionable exterior with respect to a subject, a fluid communication opening positionable within the subject to fluidically communicate with a body fluid of the subject, and an elongated lumen therebetween. A luminal wire is inserted or insertable in the elongated lumen, wherein the luminal wire has a length that is within or will be positioned with 5% to 100% of the elongated lumen. The luminal wire can have an x-y cross-sectional diameter sufficiently smaller than an x-y cross-sectional diameter of the elongated lumen to allow removal and/or insertion of the luminal wire (initially or as a replacement). The luminal wire in the present disclosure is bioactive.

A catheter including a hollow shaft having one or more curved parts. At least one curved part of the curved parts has a first region that is made of a first resin material, a second region that is provided closer to the distal end side in the longitudinal direction than the first region and is made of a second resin material having a different composition from the first resin material, and a third region that is provided adjacent to the first region and the second region and is made of a third resin material formed by mixing the first resin material and the second resin material.

The purpose of the present invention is to inhibit and prevent the formation of adhesions, i.e., bonds between a wound and its surrounding tissues or between organs that are originally separated.

The anti-adhesion material of the present invention is characterized in that at least a part of the anti-adhesion material is made of a non-biodegradable material and a contact angle of a surface to water is less than 7 degrees or more than 90 degrees.

Provided are formulations and related methods, for coating or impregnating a medical device, as well as a coated or impregnated medical device, for example, a device that is a catheter or cannula, where a different formulation may be used for interior surface of device and for exterior surface of the device.

The present invention relates to an artificial blood vessel comprising a shape-memory polymer, and a vascular anastomotic member formed of a shape-memory polymer. An artificial blood vessel according to an embodiment of the present invention comprises a shape-memory polymer including photo-crosslinkable functional groups, the artificial blood vessel thus provided having a fusion point suitable for in vivo transplantation. Also, provided is a vascular anastomotic member which comprises a shape-memory polymer including photo-crosslinkable functional groups, and thus has a fusion point suitable for in vivo transplantation.

A vascular device for insertion in a body lumen, wherein the device includes a surface including at least a portion that is a functionalized surface provided with double or more charged ions such that the ions are exposed to a bodily fluid when the vascular device is inserted in the body lumen. The vascular device allows for reducing complications in its use and, particularly, for improving a desired healing in the body and preventing restenosis. At the same time, it allows for being manufactured at comparably low effort and for a convenient handling.

Disclosed herein are methods for modifying a substrate having a hydrophobic surface. Also disclosed are modified hydrophobic substrates. The modified hydrophobic substrates and methods disclosed herein advantageously improve cell affinity and antithrombogenicity of hydrophobic surfaces.

A prosthetic tissue valve and a method of treating the prosthetic tissue valve are provided. The method includes: decreasing a temperature of a chamber carrying the prosthetic tissue valve from a first preset temperature to a second preset temperature in a first cooling rate; decreasing the temperature of the chamber carrying the prosthetic tissue valve from the second preset temperature to a third preset temperature in a second cooling rate; and performing a drying process to the prosthetic tissue valve. The second preset temperature is a critical crystallization temperature and is greater than a crystallization temperature of the prosthetic tissue valve. The third preset temperature is lower than the crystallization temperature of the prosthetic tissue valve, and the second cooling rate is greater than the first cooling rate.